Company Filing History:
Years Active: 2015
Title: Yi-Ching Wang: Innovator in Pharmaceutical Chemistry
Introduction
Yi-Ching Wang is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that have therapeutic potential.
Latest Patents
Yi-Ching Wang holds a patent for "Lithocholic acid analogues that inhibit sialyltransferase." This patent describes certain chemical entities chosen from compounds of Formula I, along with pharmaceutically acceptable salts, solvates, chelates, non-covalent complexes, prodrugs, and mixtures thereof. The patent also details pharmaceutical compositions comprising at least one chemical entity chosen from these compounds and a pharmaceutically acceptable vehicle. Furthermore, it outlines methods for inhibiting α-2,3-sialyltransferase activity in cells and methods for treating patients with diseases responsive to this inhibition.
Career Highlights
Yi-Ching Wang is affiliated with Academia Sinica, a prestigious research institution in Taiwan. His work has focused on innovative approaches to drug development, particularly in the area of sialyltransferase inhibition.
Collaborations
He has collaborated with notable colleagues, including Wen-shan Li and Hsueh-Fen Juan, contributing to advancements in their shared field of research.
Conclusion
Yi-Ching Wang's innovative work in pharmaceutical chemistry, particularly his patent on lithocholic acid analogues, showcases his commitment to advancing medical science. His contributions are significant in the ongoing quest for effective treatments for various diseases.